Change over period: —
NSE · VIJAYA
VIJAYA
-2.4% from the 52-week high · +78.0% above the low
Vijaya Diagnostic Centre Ltd. engages in the provision of diagnostic services. The company is headquartered in Hyderabad, Telangana and currently employs 1,818 full-time employees. The company went IPO on 2021-09-14. The firm is engaged in the business of providing a range of diagnostic services spanning pathological investigations, basic and high-end radiology, nuclear medicine and related healthcare services. The firm operates through the Diagnostic Services segment. Its test menu includes pathology tests ranging from basic biochemistry and clinical pathology to cytogenetics and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests, including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans, single photon emission computed tomography (SPECT) and advanced positron emission tomography CT (PET CT). The firm also offers a range of health and wellness packages to its customers as per their requirements. The firm has a diagnostic network with over 90 centers spread across 15 cities.
The short version. VIJAYA reported revenue of ₹255 crore for Sep 2026, up 26.2% from a year earlier. Net profit was ₹59 crore (up 37.2% year on year). Return on equity was 18.1% in Mar 2026. Promoter holding was 52.46% in Sep 2026, down 1.45 points over 8 quarters.
1 · The price
How has the stock traded?
VIJAYA trades 2.4% below its 52-week high and 78.0% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹255 cr.
Sep 2026 net profit of ₹59 cr.
1.8 pts higher than a year earlier.
Revenue compounded at 20.8% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 255 | 231 | 219 | 205 | 202 | 188 | 173 | 169 |
| Net profit | 59 | 53 | 48 | 43 | 43 | 38 | 35 | 35 |
| Net margin % | 23.3 | 23.0 | 21.8 | 21.0 | 21.5 | 20.4 | 20.0 | 20.8 |
| EPS (₹) | 5.77 | 5.16 | 4.66 | 4.2 | 4.21 | 3.73 | 3.37 | 3.43 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 814 | 681 | 548 | 459 | 462 |
| Net profit | 173 | 143 | 119 | 85 | 110 |
| Net margin % | 21.2 | 21.0 | 21.7 | 18.4 | 23.7 |
| EPS (₹) | 16.81 | 13.94 | 11.61 | 8.29 | 10.76 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 18.1% in Mar 2026; debt to equity is 0.00.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 18.1 | 18.0 | 18.1 | 15.5 |
| Return on capital % | 19.2 | 19.8 | 20.1 | 17.1 |
| EBITDA margin % | 42.8 | 41.5 | 42.1 | 41.4 |
| Net margin % | 20.7 | 20.4 | 20.9 | 17.9 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 20.8% | — |
| Profit CAGR | 26.9% | — |
4 · The owners
Who holds it, and are they adding?
Down 1.45 pts over 8 quarters.
Down 6.88 pts over 8 quarters.
Up 7.87 pts over 8 quarters.
+32 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.91 | 53.05 | 52.63 | 52.6 | 52.6 | 52.51 | 52.47 | 52.46 | -1.45 |
| FII | 17.54 | 19.36 | 19.56 | 18.27 | 15.1 | 13.38 | 11.65 | 10.66 | -6.88 |
| DII | 24.63 | 23.72 | 24.07 | 25.34 | 28.59 | 29.93 | 31.58 | 32.5 | +7.87 |
| Public | 3.92 | 3.87 | 3.74 | 3.79 | 3.71 | 4.18 | 4.31 | 4.38 | +0.46 |
Mutual fund holdings · Oct 2026
114 schemes hold this stock
82 the month before.
- Kotak Small Cap Fund4.4% of NAV
- Motilal Oswal Infrastructure Fund4.31% of NAV
- Kotak Business Cycle Fund3.18% of NAV
- SAMCO ELSS TAX SAVER FUND3.16% of NAV
- NIPPON INDIA PHARMA FUND2.66% of NAV
- DSP Healthcare Fund2.39% of NAV
- MOTILAL OSWAL SMALL CAP FUND2.35% of NAV
- Bajaj Finserv Healthcare Fund2.13% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for VIJAYA are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Healthcare Services stocks
Quick answers
Common questions about VIJAYA
What is the VIJAYA share price?
VIJAYA (VIJAYA) last closed at ₹1,510.60, down 1.5% on the day. Its 52-week range is ₹861.40 to ₹1,570.70.
What is the market cap of VIJAYA?
VIJAYA has a market capitalisation of about ₹15,821 crore. Its price-to-earnings ratio is 78.0.
How are VIJAYA's latest results?
VIJAYA reported revenue of ₹255 crore for Sep 2026, up 26.2% from a year earlier. Net profit was ₹59 crore (up 37.2% year on year). Return on equity was 18.1% in Mar 2026. Promoter holding was 52.46% in Sep 2026, down 1.45 points over 8 quarters.
Who owns VIJAYA?
As of Sep 2026, shareholding was: Promoter 52.46%, FII 10.66%, DII 32.5%, Public 4.38%.
How many mutual funds hold VIJAYA?
114 mutual fund schemes held VIJAYA in October 2026. That compares with 82 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 29 Aug 2025 · Final Dividend - Rs. 2
- 30 Aug 2024 · Final Dividend - Rs. 1
- 13 Sep 2023 · Dividend - Rs. 1
- 20 Sep 2022 · Final Dividend - Rs. 1
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.